Approval · Notice of Compliance 20479 · 2018
COMPONENT E-C IMPLANTS WITH TYLAN: Notice of Compliance 20479
Issued February 14, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20479
- Date
- February 14, 2018
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPONENT E-C IMPLANTS WITH TYLAN | 02245744 | Marketed |
Medicinal ingredients
- ESTRADIOL BENZOATE 10 MG per IMP
- PROGESTERONE 100 MG per IMP
- TYLOSIN TARTRATE 29 MG per IMP